Last10K.com

Respirerx Pharmaceuticals Inc. (RSPI) SEC Filing 8-K Material Event for the period ending Thursday, December 23, 2021

Respirerx Pharmaceuticals Inc.

CIK: 849636 Ticker: RSPI

View differences made from one to another to evaluate Respirerx Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Respirerx Pharmaceuticals Inc..

Continue

Assess how Respirerx Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Respirerx Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Respirerx Pharmaceuticals Inc. provided additional information to their SEC Filing as exhibits

Ticker: RSPI
CIK: 849636
Form Type: 8-K Corporate News
Accession Number: 0001493152-21-032690
Submitted to the SEC: Wed Dec 29 2021 4:05:15 PM EST
Accepted by the SEC: Wed Dec 29 2021
Period: Thursday, December 23, 2021
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation
  4. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rspi/0001493152-21-032690.htm